Evidence map›Paper›PMID 20009023›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2010

PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans.

Oleg G Chepurny, Grant G Kelley, Igor Dzhura, Colin A Leech, Michael W Roe, Elvira Dzhura, Xiangquan Li, Frank Schwede, Hans-G Genieser, George G Holz

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Oleg G ChepurnyDepartments of Medicine, State University of New York, Syracuse, 13210, USA.
Grant G Kelley
Igor Dzhura
Colin A Leech
Michael W Roe
Elvira Dzhura
Xiangquan Li
Frank Schwede
Hans-G Genieser
George G Holz
Immunovaccine (Canada) · CABiolog Life Science Institute · DE

Funding

Insulinotropin: A Modulator Of B-Cell Glucose SignalingR01DK045817 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI HOLZ, GEORGE G · 2001 to 2008
$3.0M
Molecular Basis of Antidiabetogenic Hormone ActionR01DK069575 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI HOLZ, GEORGE G · 2007 to 2017
$2.9M
Calcium Signaling in Pancreatic Beta Cell Endoplasmic ReticulumR01DK074966 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI ROE, MICHAEL WILLIAM · 2006 to 2010
$1.4M
INSULINOTROPIN: A MODULATOR OF B-CELL GLUCOSE SIGNALLINGR29DK045817 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI HOLZ, GEORGE G · 1993 to 1997
–
NIDDK NIH HHS DK-045817NIDDK NIH HHS DK-069575NIDDK NIH HHS DK-074966NIDDK NIH HHS R01 DK045817NIDDK NIH HHS R01 DK069575
6 · The paper itself

Abstract

Potential insulin secretagogue properties of an acetoxymethyl ester of a cAMP analog (8-pCPT-2'-O-Me-cAMP-AM) that activates the guanine nucleotide exchange factors Epac1 and Epac2 were assessed using isolated human islets of Langerhans. RT-QPCR demonstrated that the predominant variant of Epac expressed in human islets was Epac2, although Epac1 was detectable. Under conditions of islet perifusion, 8-pCPT-2'-O-Me-cAMP-AM (10 microM) potentiated first- and second-phase 10 mM glucose-stimulated insulin secretion (GSIS) while failing to influence insulin secretion measured in the presence of 3 mM glucose. The insulin secretagogue action of 8-pCPT-2'-O-Me-cAMP-AM was associated with depolarization and an increase of [Ca(2+)](i) that reflected both Ca(2+) influx and intracellular Ca(2+) mobilization in islet beta-cells. As expected for an Epac-selective cAMP analog, 8-pCPT-2'-O-Me-cAMP-AM (10 microM) failed to stimulate phosphorylation of PKA substrates CREB and Kemptide in human islets. Furthermore, 8-pCPT-2'-O-Me-cAMP-AM (10 microM) had no significant ability to activate AKAR3, a PKA-regulated biosensor expressed in human islet cells by viral transduction. Unexpectedly, treatment of human islets with an inhibitor of PKA activity (H-89) or treatment with a cAMP antagonist that blocks PKA activation (Rp-8-CPT-cAMPS) nearly abolished the action of 8-pCPT-2'-O-Me-cAMP-AM to potentiate GSIS. It is concluded that there exists a permissive role for PKA activity in support of human islet insulin secretion that is both glucose dependent and Epac regulated. This permissive action of PKA may be operative at the insulin secretory granule recruitment, priming, and/or postpriming steps of Ca(2+)-dependent exocytosis.

Indexed as

Cells, CulturedCyclic AMPCyclic AMP-Dependent Protein KinasesDose-Response Relationship, DrugDrug SynergismGlucoseGuanine Nucleotide Exchange FactorsHumansInsulinInsulin SecretionIslets of LangerhansSignal Transduction8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphateCyclic AMPCyclic AMP-Dependent Protein KinasesEpac protein, mouseGlucoseGuanine Nucleotide Exchange FactorsInsulinRAPGEF3 protein, human

Identifiers

PMID20009023
PMCPMC2838523
OpenAlexW2141142179

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.